Ted Brezel, MD
Procedural Dermatology · Glendale, NYNPI 1831152115
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.1% of the total across 255 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 19.2% — the pattern of someone who eats at a lot of different presentations.
Across 255 payments — averaging $21.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Novartis$525
- Lilly USA, LLC$465
- UCB, Inc.$448
- Regeneron Healthcare Solutions, Inc.$437
- E.r. Squibb & Sons, L.L.C.$404
- plus $2K from 20 others
What the payments were for
- Food & beverage$5,27996%
- Education$2144%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 59 | $1,056 |
| Novartis | 28 | $525 |
| Lilly USA, LLC | 22 | $465 |
| UCB, Inc. | 23 | $448 |
| Regeneron Healthcare Solutions, Inc. | 21 | $437 |
| E.r. Squibb & Sons, L.L.C. | 16 | $404 |
| Johnson & Johnson | 12 | $372 |
| Pfizer | 11 | $280 |
| Merz North America, Inc. | 5 | $233 |
| Sun Pharmaceutical Industries Inc. | 10 | $230 |
| Amgen | 9 | $227 |
| Galderma Laboratories, L.p. | 9 | $190 |
| Sanofi | 6 | $123 |
| Incyte Corporation | 5 | $111 |
| EPI Health, LLC | 4 | $79 |
| Botanix SB Inc | 2 | $55 |
| Encore Dermatology Inc. | 2 | $40 |
| LEO Pharma Inc. | 2 | $39 |
| Merck | 2 | $34 |
| Kyowa Kirin, Inc. | 1 | $27 |
| Verrica Pharmaceuticals Inc. | 1 | $24 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $20 |
| Arcutis Biotherapeutics, Inc. | 1 | $19 |
| Aclaris Therapeutics, Inc. | 1 | $19 |
| Bristol Myers Squibb | 1 | $18 |
| Helsinn Therapeutics (U.S.), Inc. | 1 | $18 |
How this compares
$5,492 in reported general payments places this provider in the 55th percentile of 69 procedural dermatology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent SyringeDupilumab | 13 | $50,426 |
| Diflorasone Diacetate | 12 | $7,075 |
| Fluocinonide | 79 | $3,068 |
| Clobetasol Propionate | 53 | $2,694 |
| Triamcinolone Acetonide | 95 | $1,279 |
| Desonide | 12 | $1,056 |
| Ketoconazole | 70 | $1,013 |
| Metronidazole | 22 | $974 |
| Clindamycin Phosphate | 41 | $871 |
| Mometasone Furoate | 55 | $860 |
| Econazole Nitrate | 20 | $624 |
| Cephalexin | 23 | $545 |
| Ammonium Lactate | 20 | $485 |
| Halobetasol Propionate | 11 | $482 |
| Alclometasone Dipropionate | 12 | $470 |
Paid to pharmacies, not to this prescriber.
Other procedural dermatology in Glendale
- Joseph SchwartzTroy$470K
- Michelle HenryNew York$460K
- Jerry ShapiroNew York$414K
- Jared JagdeoBrooklyn$362K
- Dendy EngelmanNew York$292K
- Evan RiederNew York$210K
- Daniel Belkin-HollandNew York$208K
- Suzanne Sirota-RozenbergWoodmere$122K
- Robert BacigalupiGarden City$109K
- Anthony ChiaravallotiEast Syracuse$90K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.